Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 834291, 15 pages
http://dx.doi.org/10.1155/2012/834291
Review Article

Cutaneous Manifestations of Systemic Lupus Erythematosus

Faculdade de Medicina de Lisboa, Clinica Universitária de Dermatologia, Avenido Prof. Egas Moniz, 1649-035 Lisboa, Portugal

Received 4 May 2012; Accepted 4 June 2012

Academic Editor: Hiroshi Okamoto

Copyright © 2012 Luís Uva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, article 1725, 1997. View at Google Scholar · View at Scopus
  2. R. Klein, S. Moghadam-Kia, J. LoMonico et al., “Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus,” Archives of Dermatology, vol. 147, no. 2, pp. 203–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. E. M. Tan, A. S. Cohen, and J. F. Fries, “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis and Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Google Scholar · View at Scopus
  4. L. C. Parish, R. J. Kennedy, and J. Hurley, “Palmar lesions in lupus erythematosus,” Archives of Dermatology, vol. 96, no. 3, pp. 273–276, 1967. View at Publisher · View at Google Scholar · View at Scopus
  5. C. R. Spann, J. P. Callen, J. B. Klein, and K. B. Kulick, “Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and/or hypertrophic skin lesions,” Journal of Rheumatology, vol. 15, no. 2, pp. 256–261, 1988. View at Google Scholar · View at Scopus
  6. P. B. Martens, K. G. Moder, and I. Ahmed, “Lupus panniculitis: clinical perspectives from a case series,” Journal of Rheumatology, vol. 26, no. 1, pp. 68–72, 1999. View at Google Scholar · View at Scopus
  7. A. Kuhn, M. Sticherling, and G. Bonsmann, “Clinical manifestations of cutaneous lupus erythematosus,” JDDG, vol. 5, no. 12, pp. 1124–1137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Panjwani, “Early diagnosis and treatment of discoid lupus erythematosus,” JABFM, vol. 22, no. 2, pp. 206–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Albrecht and V. P. Werth, “Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus,” Dermatologic Therapy, vol. 20, no. 2, pp. 93–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Y. Finlay, “Quality of life measurement in dermatology: a practical guide,” British Journal of Dermatology, vol. 136, no. 3, pp. 305–314, 1997. View at Google Scholar · View at Scopus
  11. S. D. Prystowsky and J. N. Gilliam, “Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus,” Archives of Dermatology, vol. 111, no. 11, pp. 1448–1452, 1975. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Kuhn, M. Herrmann, S. Kleber et al., “Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation,” Arthritis and Rheumatism, vol. 54, no. 3, pp. 939–950, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Baumann, W. Kolowos, R. E. Voll et al., “Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 46, no. 1, pp. 191–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. U. S. Gaipl, A. Kuhn, A. Sheriff et al., “Clearance of apoptotic cells in human SLE,” Current Directions in Autoimmunity, vol. 9, pp. 173–187, 2006. View at Google Scholar · View at Scopus
  15. D. A. Abdulahad, J. Westra, P. C. Limburg, C. G. M. Kallenberg, and M. Bijl, “HMGB1 in systemic lupus Erythematosus: its role in cutaneous lesions development,” Autoimmunity Reviews, vol. 9, no. 10, pp. 661–665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. V. Suschek, V. Krischel, D. Bruch-Gerharz et al., “Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation,” The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6130–6137, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Kuhn, K. Fehsel, P. Lehmann, J. Krutmann, T. Ruzicka, and V. Kolb-Bachofen, “Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus,” Journal of Investigative Dermatology, vol. 111, no. 1, pp. 149–153, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. H. M. Belmont, D. Levartovsky, A. Goel et al., “Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 10, pp. 1810–1816, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kuhn, P. H. Krammer, and V. Kolb-Bachofen, “Pathophysiology of cutaneous lupus erythematosus—novel aspects,” Rheumatology, vol. 45, supplement 3, pp. iii14–iii16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wenzel and T. Tüting, “Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches,” Experimental Dermatology, vol. 16, no. 5, pp. 454–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Wenzel, M. Uerlich, E. Wörrenkämper, S. Freutel, T. Bieber, and T. Tüting, “Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA,” British Journal of Dermatology, vol. 153, no. 5, pp. 1011–1015, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Uehara, X. X. Peng, B. Bennett et al., “c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation,” Transplantation, vol. 78, no. 3, pp. 324–332, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Uehara, B. Bennett, S. T. Sakata et al., “JNK mediates hepatic ischemia reperfusion injury,” Journal of Hepatology, vol. 42, no. 6, pp. 850–859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Caricchio, L. McPhie, and P. L. Cohen, “Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution,” Journal of Immunology, vol. 171, no. 11, pp. 5778–5786, 2003. View at Google Scholar · View at Scopus
  25. R. Korhonen, K. Linker, A. Pautz, U. Förstermann, E. Moilanen, and H. Kleinert, “Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase,” Molecular Pharmacology, vol. 71, no. 5, pp. 1427–1434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Sakaguchi, “Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self,” Nature Immunology, vol. 6, no. 4, pp. 345–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. Crispin, A. Martínez, and J. Alcocer-Varela, “Quantification of regulatory T cells in patients with systemic lupus erythematosus,” Journal of Autoimmunity, vol. 21, no. 3, pp. 273–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Miyara, Z. Amoura, C. Parizot et al., “Global natural regulatory T cell depletion in active systemic lupus erythematosus,” Journal of Immunology, vol. 175, no. 12, pp. 8392–8400, 2005. View at Google Scholar · View at Scopus
  29. S. Meller, F. Winterberg, M. Gilliet et al., “Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus,” Arthritis and Rheumatism, vol. 52, no. 5, pp. 1504–1516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Wenzel, S. Henze, E. Wörenkämper et al., “Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus,” Journal of Investigative Dermatology, vol. 124, no. 6, pp. 1241–1248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Furukawa and T. Yoshimasu, “Animal models of spontaneous and drug-induced cutaneous lupus erythematosus,” Autoimmunity Reviews, vol. 4, no. 6, pp. 345–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. G. J. Pons-Estel, G. S. Alarcón, L. A. González et al., “Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort,” Arthritis Care and Research, vol. 62, no. 3, pp. 393–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Ezra and J. Jorizzo, “Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus,” Clinical and Experimental Dermatology, vol. 37, no. 4, pp. 327–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Dutz and V. P. Werth, “Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma,” Journal of Investigative Dermatology, vol. 131, no. 10, pp. 1968–1970, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. P. Callen, “Update on the management of cutaneous lupus erythematosus,” British Journal of Dermatology, vol. 151, no. 4, pp. 731–736, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Jonsson, G. Heyden, N. G. Westberg, and G. Nyberg, “Oral mucosal lesions in systemic lupus erythematosus—a clinical, histopathological and immunopathological study,” Journal of Rheumatology, vol. 11, no. 1, pp. 38–42, 1984. View at Google Scholar · View at Scopus
  37. J. D. Urman, M. B. Lowenstein, M. Abeles, and A. Weinstein, “Oral mucosal ulceration in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 21, no. 1, pp. 58–61, 1978. View at Google Scholar · View at Scopus
  38. M. Schiodt, “Oral discoid lupus erythematosus. III. A histopathologic study of sixty-six patients,” Oral Surgery Oral Medicine and Oral Pathology, vol. 57, no. 3, pp. 281–293, 1984. View at Google Scholar · View at Scopus
  39. E. L. Dubois and D. L. Tuffanelli, “Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases,” JAMA, vol. 190, pp. 104–111, 1964. View at Google Scholar · View at Scopus
  40. J. F. Fries and H. R. Holman, “Systemic lupus erythematosus: a clinical analysis,” Major Problems in Internal Medicine, vol. 6, 1975. View at Google Scholar · View at Scopus
  41. A. M. Harvey, L. E. Shulman, P. A. Tumulty, C. L. Conley, and E. H. Schoenrich, “Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases,” Medicine, vol. 33, no. 4, pp. 291–437, 1954. View at Google Scholar
  42. D. Estes and C. L. Christian, “The natural history of systemic lupus erythematosus by prospective analysis,” Medicine, vol. 50, no. 2, pp. 85–95, 1971. View at Google Scholar · View at Scopus
  43. Z. Al Rawi, H. Al Shaarbaf, E. Al Raheem, and S. J. Khalifa, “Clinical features of early cases of systemic lupus erythematosus in Iraqi patients,” British Journal of Rheumatology, vol. 22, no. 3, pp. 165–171, 1983. View at Google Scholar · View at Scopus
  44. E. B. Tsianos, A. G. Tzioufas, and M. D. Kita, “Serum isoamylases in patients with autoimmune rheumatic diseases,” Clinical and Experimental Rheumatology, vol. 2, no. 3, pp. 235–238, 1984. View at Google Scholar · View at Scopus
  45. M. C. Hochberg, R. E. Boyd, and J. M. Ahearn, “Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets,” Medicine, vol. 64, no. 5, pp. 285–295, 1985. View at Google Scholar · View at Scopus
  46. M. Pistiner, D. J. Wallace, S. Nessim, A. L. Metzger, and J. R. Klinenberg, “Lupus erythematosus in the 1980s: a survey of 570 patients,” Seminars in Arthritis and Rheumatism, vol. 21, no. 1, pp. 55–64, 1991. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Vitali, W. Bencivelli, D. A. Isenberg et al., “Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an acticity score,” Clinical and Experimental Rheumatology, vol. 10, no. 5, pp. 541–547, 1992. View at Google Scholar · View at Scopus
  48. C. Vitali, A. Doria, A. Tincani et al., “International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement,” Clinical and Experimental Rheumatology, vol. 14, supplement 16, pp. S17–S22, 1996. View at Google Scholar · View at Scopus
  49. J. T. Jakes, E. L. Dubois, and F. P. Quismorio, “Antileprosy drugs and lupus erythematosus,” Annals of Internal Medicine, vol. 97, no. 5, p. 788, 1982. View at Google Scholar · View at Scopus
  50. R. P. Hall, T. J. Lawley, H. R. Smith, and S. I. Katz, “Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy,” Annals of Internal Medicine, vol. 97, no. 2, pp. 165–170, 1982. View at Google Scholar · View at Scopus
  51. A. E. Soto-Rojas, A. R. Villa, J. Sifuentes-Osornio, D. Alarcón-Segovia, and A. Kraus, “Oral manifestations in patients with Sjogren's syndrome,” Journal of Rheumatology, vol. 25, no. 5, pp. 906–910, 1998. View at Google Scholar · View at Scopus
  52. K. Al-Refu and M. Goodfield, “Hair follicle stem cells in the pathogenesis of the scarring process in cutaneous lupus erythematosus,” Autoimmunity Reviews, vol. 8, no. 6, pp. 474–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. R. D. Sontheimer, “Subacute cutaneous lupus erythematosus: 25-Year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings,” Autoimmunity Reviews, vol. 4, no. 5, pp. 253–263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. T. S. Housman, J. L. Jorizzo, M. A. McCarty, S. E. Grummer, A. B. Fleischer, and P. G. Sutej, “Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus,” Archives of Dermatology, vol. 139, no. 1, pp. 50–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Sticherling, G. Bonsmann, and A. Kuhn, “Diagnostic approach and treatment of cutaneous lupus erythematosus,” JDDG, vol. 6, no. 1, pp. 48–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Usmani and M. Goodfield, “Efalizumab in the treatment of discoid lupus erythematosus,” Archives of Dermatology, vol. 143, no. 7, pp. 873–877, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. T. B. S. Burns, N. Cox, and C. Griffiths, Lichen Planus and Lichenoid Disorders. Rook?s Textbook of Dermatology, Wiley-Blackwel, Oxford, UK, 8th edition, 2010.
  58. A. Fayyazi, S. Schweyer, A. Soruri et al., “T lymphocytes and altered keratinocytes express interferon-γ and interleukin 6 in lichen planus,” Archives of Dermatological Research, vol. 291, no. 9, pp. 485–490, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Khan, C. S. Farah, N. W. Savage, L. J. Walsh, D. J. Harbrow, and P. B. Sugerman, “Th1 cytokines in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 32, no. 2, pp. 77–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. J. N. W. N. Barker, H. A. Navsaria, I. M. Leigh, and D. M. MacDonald, “Gamma-interferon induced human keratinocyte HLA-DR synthesis: the role of dermal activated T lymphocytes,” British Journal of Dermatology, vol. 119, no. 5, pp. 567–572, 1988. View at Google Scholar · View at Scopus
  61. Z. Z. Zhao, P. B. Sugerman, L. J. Walsh, and N. W. Savage, “Expression of RANTES and CCR1 in oral lichen planus and association with mast cell migration,” Journal of Oral Pathology and Medicine, vol. 31, no. 3, pp. 158–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Iijima, H. Ohtani, T. Nakayama et al., “Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism,” American Journal of Pathology, vol. 163, no. 1, pp. 261–268, 2003. View at Google Scholar · View at Scopus
  63. M. C. Little, C. E. M. Griffiths, R. E. B. Watson, M. N. Pemberton, and M. H. Thornhill, “Oral mucosal keratinocytes express RANTES and ICAM-1, but not interleukin-8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings,” Clinical and Experimental Dermatology, vol. 28, no. 1, pp. 64–69, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Cribier, C. Frances, and O. Chosidow, “Treatment of lichen planus: an evidence-based medicine analysis of efficacy,” Archives of Dermatology, vol. 134, no. 12, pp. 1521–1530, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Omidian, A. Ayoobi, M. Mapar, A. Feily, and B. Cheraghian, “Efficacy of sulfasalazine in the treatment of generalized lichen planus: randomized double-blinded clinical trial on 52 patients,” Journal of the European Academy of Dermatology and Venereology, vol. 24, no. 9, pp. 1051–1054, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. V. P. Werth, “Clinical manifestations of cutaneous lupus erythematosus,” Autoimmunity Reviews, vol. 4, no. 5, pp. 296–302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. F. M. Wigley, “Raynaud's phenomenon,” The New England Journal of Medicine, vol. 347, no. 13, pp. 1001–1008, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. B. Goundry, L. Bell, M. Langtree, and A. Moorthy, “Diagnosis and management of Raynaud's phenomenon,” BMJ, vol. 344, article e289, 2012. View at Google Scholar · View at Scopus
  69. E. M. Vital, S. Dass, M. H. Buch et al., “Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al,” Arthritis and Rheumatism, vol. 60, no. 6, p. 1867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Postal, L. T. Costallat, and S. Appenzeller, “Biological therapy in systemic lupus erythematosus,” International Journal of Rheumatology, vol. 2012, Article ID 578641, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. E. G. Boyce and B. E. Fusco, “Belimumab: review of use in systemic lupus erythematosus,” Clinical Therapeutics, vol. 34, no. 5, pp. 1006–1022, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. J. J. Wisnieski, “Urticarial vasculitis,” Current Opinion in Rheumatology, vol. 12, no. 1, pp. 24–31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Venzor, W. L. Lee, and D. P. Huston, “Urticarial vasculitis,” Clinical Reviews in Allergy and Immunology, vol. 23, no. 2, pp. 201–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. J. J. Wisnieski, A. N. Baer, J. Christensen et al., “Hypocomplementemic urticarial vasculitis syndrome: clinical and serologic findings in 18 patients,” Medicine, vol. 74, no. 1, pp. 24–41, 1995. View at Publisher · View at Google Scholar · View at Scopus
  75. C. E. H. Siegert, M. D. Kazatchkine, A. Sjöholm, R. Würzner, M. Loos, and M. R. Daha, “Autoantibodies against C1q: view on clinical relevance and pathogenic roles,” Clinical and Experimental Immunology, vol. 116, no. 1, pp. 4–8, 1999. View at Google Scholar · View at Scopus
  76. M. Y. Her, J. Y. Song, and D. Y. Kim, “Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus,” Journal of Korean Medical Science, vol. 24, no. 1, pp. 184–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. R. N. V. Furtado, M. L. C. Pucinelli, V. V. Cristo, L. E. C. Andrade, and E. I. Sato, “Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients,” Lupus, vol. 11, no. 1, pp. 35–41, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Cardinali, M. Caproni, E. Bernacchi, L. Amato, and P. Fabbri, “The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience,” Lupus, vol. 9, no. 6, pp. 417–423, 2000. View at Google Scholar · View at Scopus
  79. R. P. B. Rapini, L. Jean, Jorizzo, and L. Joseph, Dermatology, vol. 2, Mosby, St. Louis, Mo, USA, 2007.
  80. C. Herrero, A. Guilabert, and J. M. Mascaró-Galy, “Diagnosis and treatment of livedo reticularis on the legs,” Actas Dermo-Sifiliograficas, vol. 99, no. 8, pp. 598–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Y. K. Kwok and W. K. Cheong, “Atrophie blanche—a special form of vasculopathy,” Singapore Medical Journal, vol. 38, no. 3, pp. 123–124, 1997. View at Google Scholar · View at Scopus
  82. L. M. Milstone, I. M. Braverman, P. Lucky, and P. Fleckman, “Classification and therapy of atrophie blanche,” Archives of Dermatology, vol. 119, no. 12, pp. 963–969, 1983. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Elisaf, S. Nikou-Stefanaki, A. A. Drosos, and H. M. Moutsopoulos, “Atrophie blanche. Clinical diagnosis and treatment,” Annales de Medecine Interne, vol. 142, no. 6, pp. 415–418, 1991. View at Google Scholar · View at Scopus
  84. C. S. McCalmont, T. H. McCalmont, J. L. Jorizzo, W. L. White, B. Leshin, and H. Rothberger, “Livedo vasculitis: vasculitis or thrombotic vasculopathy?” Clinical and Experimental Dermatology, vol. 17, no. 1, pp. 4–8, 1992. View at Google Scholar · View at Scopus
  85. J. K. Shornick, B. K. Nicholes, P. R. Bergstresser, and J. N. Gilliam, “Idiopathic atrophie blanche,” Journal of the American Academy of Dermatology, vol. 8, no. 6, pp. 792–798, 1983. View at Google Scholar · View at Scopus
  86. C. R. Drucker and W. C. Duncan, “Antiplatelet therapy in atrophie blanche and livedo vasculitis,” Journal of the American Academy of Dermatology, vol. 7, no. 3, pp. 359–363, 1982. View at Google Scholar · View at Scopus
  87. G. C. Sauer, “Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche,” Archives of Dermatology, vol. 122, no. 4, pp. 380–381, 1986. View at Google Scholar · View at Scopus
  88. R. L. Jetton and G. S. Lazarus, “Minidose heparin therapy for vasculitis of atrophie blanche,” Journal of the American Academy of Dermatology, vol. 8, no. 1, pp. 23–26, 1983. View at Google Scholar · View at Scopus
  89. E. A. I. M. Freedberg, K. Wolff et al., Katz SI. Dermatitis Herpetiformis. Fitzpatrick's Dermatology in General Medicine, McGraw-Hill, Health Professions Division, New York, 5th edition, 1999.
  90. A. Dupuy, M. Viguier, C. Bédane et al., “Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody),” Archives of Dermatology, vol. 140, no. 1, pp. 91–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. A. R. Ahmed, Z. Spigelman, L. A. Cavacini, and M. R. Posner, “Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin,” The New England Journal of Medicine, vol. 355, no. 17, pp. 1772–1779, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. F. Wojnarowska, R. A. Marsden, B. Bhogal, and M. M. Black, “Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults: a comparative study demonstrating clinical and immunopathologic overlap,” Journal of the American Academy of Dermatology, vol. 19, no. 5, part 1, pp. 792–805, 1988. View at Google Scholar · View at Scopus
  93. F. E. R. Wojnarovska and S. Burge, “Bullous eruptions,” in Textbook of Dermatology, R. H. Champion, Ed., pp. 1880–1883, Blackwell, Oxford, UK, 6th edition, 1998. View at Google Scholar
  94. P. Patrício, C. Ferreira, M. M. Gomes, and P. Filipe, “Autoimmune bullous dermatoses: a review,” Annals of the New York Academy of Sciences, vol. 1173, pp. 203–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. A. M. Alahlafi, P. Wordsworth, and F. Wojnarowska, “The lupus band: do the autoantibodies target collagen VII?” British Journal of Dermatology, vol. 150, no. 3, pp. 504–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. A. M. Alahlafi, P. Wordsworth, L. Lakasing, D. Davies, and F. Wojnarowska, “The basement membrane zone in patients with systemic lupus erythematosus: immunofluorescence studies in the skin, kidney and amniochorion,” Lupus, vol. 13, no. 8, pp. 594–600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Doria, C. Biasinutto, A. Ghirardello et al., “Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition,” Lupus, vol. 5, no. 4, pp. 263–268, 1996. View at Google Scholar · View at Scopus
  98. J. Albrecht, J. A. Berlin, I. M. Braverman et al., “Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus,” Lupus, vol. 13, no. 11, pp. 839–849, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Kuhn, M. Sonntag, D. Richter-Hintz et al., “Phototesting in lupus erythematosus: a 15-year experience,” Journal of the American Academy of Dermatology, vol. 45, no. 1, pp. 86–95, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Petri, A. M. Orbai, G. S. Alarcón et al., “Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus,” Arthritis and Rheumatism, 2012. In press.